The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss.The agency first ...

The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no ...

CHICAGO — A shooting inside a car dealership on the city’s Southwest Side left two people injured on Thursday afternoon.

Maryland Attorney General Anthony G. Brown has joined forces with a 37-state coalition to urge the Food and Drug ...

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report payments to healthcare and patient organisations.

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Cue the advent of Glucagon-like peptide 1 agonists (GLP-1s) such as Ozempic and Wegovy. First approved by the FDA in 2005 for type 2 diabetes, Ozempic showed incredible promise in not only ...

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people with Parkinson’s disease, according to a new study. Researchers ...

Ozempic and Wegovy has been prescribed to Yorkshire patients hundreds of times in the past year - and it's not for weightloss. According to data from the NHS' Open Prescribing service, semaglutide ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient ...

While Novo’s type 2 diabetes GLP-1 Ozempic has largely stolen the show in recent years, obesity med Wegovy—which utilizes the same molecule semaglutide at higher doses than Ozempic ...